We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety Study of Parathyroid Hormone in Patients Needing Additional Stem Cell Mobilization.

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00299780
First Posted: March 7, 2006
Last Update Posted: April 24, 2007
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Dana-Farber Cancer Institute
Beth Israel Deaconess Medical Center
Information provided by:
Massachusetts General Hospital
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: April 2007
  Primary Completion Date: No date given